GLP-1 Receptor Agonist Drugs As a Protective Factor Against Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus. RSD 2021, 10 (16), e134101623517. https://doi.org/10.33448/rsd-v10i16.23517.